Boston Scientific earnings were $2.5B for the trailing 12 months ending Jun 30, 2025, with 37.1% growth year over year. The latest BSX earnings report on Jun 30, 2025 announced Q2 2025 earnings of $797.0M, up 18.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BSX reported annual earnings of $1.9B, with 18% growth.
BSX past earnings growth
How has BSX's earnings growth performed historically?
What were Boston Scientific's earnings last quarter?
On BSX's earnings call on Invalid Date, Boston Scientific (NYSE: BSX) reported Q2 2025 earnings per share (EPS) of $0.54, up 145.45% year over year. Total BSX earnings for the quarter were $797.00 million. In the same quarter last year, Boston Scientific's earnings per share (EPS) was $0.22.
As of the last Boston Scientific earnings report, Boston Scientific is currently profitable. Boston Scientific's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $2.51 billion, a 37.11% increase year over year.
What was BSX's earnings growth in the past year?
As of Boston Scientific's earnings date in Invalid Date, Boston Scientific's earnings has grown 37.1% year over year. This is 34.23 percentage points lower than the US Medical Devices industry earnings growth rate of 71.32%. BSX earnings in the past year totalled $2.51 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.